ACC 2024 Insights
M

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With or Without Chronic Kidney Disease and/or Diabetes

By ACC 2024 Insights FEATURING Maria Costanzo
By ACC 2024 Insights FEATURING Maria Costanzo
2,106 views
April 16, 2024

Chapters

Introduction & Guideline-Directed Medical Therapy

00:00

ARNI in HFrEF & HFpEF

01:33

ARNI's Renal Effects & Albuminuria

07:17

ARNI & Diabetes Management

12:43

SGLT2 Inhibitors' Broad Impact

15:09

Mechanisms of SGLT2 Inhibitors

20:48

Finerenone & Cardio-Kidney-Metabolic Syndrome

24:54

Conclusion: Therapies Across Conditions

29:23

Comments 2
Login to view comments. Click here to Login

Featured Video

13:03
Novartis Cardiology

Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…

Feat. M. Koren

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.2K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.3K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

20.7K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.1K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.2K views
15:06

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

8.8K views
12:26

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

11.4K views
37:21

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

10.6K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.5K views
08:35

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

7.6K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.5K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.6K views
15:33

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

8.0K views
07:41

Weightloss in Menopause

Susan Brian

6.0K views
26:49

Tirzepatide Updates

Diana Isaacs

8.1K views
26:57

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Houston Methodist

T. R. Mccarty

53 views
40:48

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

207 views
05:08

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

3.3K views
09:52

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views
13:07

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

6.3K views
AUTOPLAY